The feasibility and utility of level III portable sleep studies in the pediatric inpatient setting

Gurinder Singh, Kimberly Hardin, Heejung Bang, Kiran Nandalike

Research output: Contribution to journalArticle

Abstract

Study Objectives: Sleep-disordered breathing (SDB) may significantly impact the course of medical illness in hospitalized children. Polysomnography (PSG) is the gold standard for establishing diagnosis of SDB, but its availability is limited. The aim of this study was to explore the feasibility and utility of level III portable sleep studies in hospitalized children with SDB. Methods: A retrospective study was conducted at a tertiary hospital over the preceding 2 years in hospitalized children < 18 years who had undergone a level III sleep study using the Nox T3 system. The information obtained included demographic data, comorbidities, indication for admission and sleep study, time interval between the study ordered and done, adequacy of technical data from sleep study, study diagnosis, and subsequent management interventions for SDB. Results: A total of 51 hospitalized children had these studies; 32 were female and mean age was 4.3 years. Approximately 90% of children had significant comorbidities, including neurological and craniofacial abnormalities. The majority (80%) of studies were conducted within 24 hours of the time requested and 92.1% studies had technically adequate data for analysis. Thirty-nine (76.5%) children were identified with SDB; all but one patient underwent therapy for SDB during that same hospitalization, including supplemental oxygen (48.7%), positive airway pressure therapy (23%), surgical intervention (38.2%) or caffeine (10.2%). Twelve percent of children had more than one intervention done. Conclusions: The level III portable sleep study is readily available, sufficient to diagnose SDB, and help to provide appropriate medical and/or surgical therapies in hospitalized children with complex medical conditions.

Original languageEnglish (US)
Pages (from-to)985-990
Number of pages6
JournalJournal of Clinical Sleep Medicine
Volume15
Issue number7
DOIs
StatePublished - Jan 1 2019

Fingerprint

Sleep Apnea Syndromes
Inpatients
Hospitalized Child
Sleep
Pediatrics
Comorbidity
Craniofacial Abnormalities
Polysomnography
Caffeine
Tertiary Care Centers
Hospitalization
Therapeutics
Retrospective Studies
Demography
Oxygen
Pressure

Keywords

  • High risk comorbidities
  • Inpatient
  • Level III portable sleep studies
  • Obstructive sleep apnea
  • Pediatric
  • Sleep-disordered breathing

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Neurology
  • Clinical Neurology

Cite this

The feasibility and utility of level III portable sleep studies in the pediatric inpatient setting. / Singh, Gurinder; Hardin, Kimberly; Bang, Heejung; Nandalike, Kiran.

In: Journal of Clinical Sleep Medicine, Vol. 15, No. 7, 01.01.2019, p. 985-990.

Research output: Contribution to journalArticle

@article{43b7786c637c47cda0353e20aea306cb,
title = "The feasibility and utility of level III portable sleep studies in the pediatric inpatient setting",
abstract = "Study Objectives: Sleep-disordered breathing (SDB) may significantly impact the course of medical illness in hospitalized children. Polysomnography (PSG) is the gold standard for establishing diagnosis of SDB, but its availability is limited. The aim of this study was to explore the feasibility and utility of level III portable sleep studies in hospitalized children with SDB. Methods: A retrospective study was conducted at a tertiary hospital over the preceding 2 years in hospitalized children < 18 years who had undergone a level III sleep study using the Nox T3 system. The information obtained included demographic data, comorbidities, indication for admission and sleep study, time interval between the study ordered and done, adequacy of technical data from sleep study, study diagnosis, and subsequent management interventions for SDB. Results: A total of 51 hospitalized children had these studies; 32 were female and mean age was 4.3 years. Approximately 90{\%} of children had significant comorbidities, including neurological and craniofacial abnormalities. The majority (80{\%}) of studies were conducted within 24 hours of the time requested and 92.1{\%} studies had technically adequate data for analysis. Thirty-nine (76.5{\%}) children were identified with SDB; all but one patient underwent therapy for SDB during that same hospitalization, including supplemental oxygen (48.7{\%}), positive airway pressure therapy (23{\%}), surgical intervention (38.2{\%}) or caffeine (10.2{\%}). Twelve percent of children had more than one intervention done. Conclusions: The level III portable sleep study is readily available, sufficient to diagnose SDB, and help to provide appropriate medical and/or surgical therapies in hospitalized children with complex medical conditions.",
keywords = "High risk comorbidities, Inpatient, Level III portable sleep studies, Obstructive sleep apnea, Pediatric, Sleep-disordered breathing",
author = "Gurinder Singh and Kimberly Hardin and Heejung Bang and Kiran Nandalike",
year = "2019",
month = "1",
day = "1",
doi = "10.5664/jcsm.7878",
language = "English (US)",
volume = "15",
pages = "985--990",
journal = "Journal of Clinical Sleep Medicine",
issn = "1550-9389",
publisher = "American Academy of Sleep Medicine",
number = "7",

}

TY - JOUR

T1 - The feasibility and utility of level III portable sleep studies in the pediatric inpatient setting

AU - Singh, Gurinder

AU - Hardin, Kimberly

AU - Bang, Heejung

AU - Nandalike, Kiran

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Study Objectives: Sleep-disordered breathing (SDB) may significantly impact the course of medical illness in hospitalized children. Polysomnography (PSG) is the gold standard for establishing diagnosis of SDB, but its availability is limited. The aim of this study was to explore the feasibility and utility of level III portable sleep studies in hospitalized children with SDB. Methods: A retrospective study was conducted at a tertiary hospital over the preceding 2 years in hospitalized children < 18 years who had undergone a level III sleep study using the Nox T3 system. The information obtained included demographic data, comorbidities, indication for admission and sleep study, time interval between the study ordered and done, adequacy of technical data from sleep study, study diagnosis, and subsequent management interventions for SDB. Results: A total of 51 hospitalized children had these studies; 32 were female and mean age was 4.3 years. Approximately 90% of children had significant comorbidities, including neurological and craniofacial abnormalities. The majority (80%) of studies were conducted within 24 hours of the time requested and 92.1% studies had technically adequate data for analysis. Thirty-nine (76.5%) children were identified with SDB; all but one patient underwent therapy for SDB during that same hospitalization, including supplemental oxygen (48.7%), positive airway pressure therapy (23%), surgical intervention (38.2%) or caffeine (10.2%). Twelve percent of children had more than one intervention done. Conclusions: The level III portable sleep study is readily available, sufficient to diagnose SDB, and help to provide appropriate medical and/or surgical therapies in hospitalized children with complex medical conditions.

AB - Study Objectives: Sleep-disordered breathing (SDB) may significantly impact the course of medical illness in hospitalized children. Polysomnography (PSG) is the gold standard for establishing diagnosis of SDB, but its availability is limited. The aim of this study was to explore the feasibility and utility of level III portable sleep studies in hospitalized children with SDB. Methods: A retrospective study was conducted at a tertiary hospital over the preceding 2 years in hospitalized children < 18 years who had undergone a level III sleep study using the Nox T3 system. The information obtained included demographic data, comorbidities, indication for admission and sleep study, time interval between the study ordered and done, adequacy of technical data from sleep study, study diagnosis, and subsequent management interventions for SDB. Results: A total of 51 hospitalized children had these studies; 32 were female and mean age was 4.3 years. Approximately 90% of children had significant comorbidities, including neurological and craniofacial abnormalities. The majority (80%) of studies were conducted within 24 hours of the time requested and 92.1% studies had technically adequate data for analysis. Thirty-nine (76.5%) children were identified with SDB; all but one patient underwent therapy for SDB during that same hospitalization, including supplemental oxygen (48.7%), positive airway pressure therapy (23%), surgical intervention (38.2%) or caffeine (10.2%). Twelve percent of children had more than one intervention done. Conclusions: The level III portable sleep study is readily available, sufficient to diagnose SDB, and help to provide appropriate medical and/or surgical therapies in hospitalized children with complex medical conditions.

KW - High risk comorbidities

KW - Inpatient

KW - Level III portable sleep studies

KW - Obstructive sleep apnea

KW - Pediatric

KW - Sleep-disordered breathing

UR - http://www.scopus.com/inward/record.url?scp=85069036202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069036202&partnerID=8YFLogxK

U2 - 10.5664/jcsm.7878

DO - 10.5664/jcsm.7878

M3 - Article

AN - SCOPUS:85069036202

VL - 15

SP - 985

EP - 990

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

SN - 1550-9389

IS - 7

ER -